盘后时段
|
||||
|
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.82/-0.01
|
|
企业价值
16.75M
|
| 资产负债 |
|
每股账面净值
-0.44
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
37.32M
|
|
每股收益
2.72
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟:2025/11/07 18:37 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products,which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. |

1.0764 
